Edgewell Personal Care Reports Decline in Q3 and Nine-Month Financial Performance for Fiscal 2025

Edgewell Personal Care Company reported a decline in financial performance for the third quarter and first nine months of fiscal 2025, as detailed in its latest 10-Q filing. For the three months ended June 30, 2025, net sales decreased by 3.2% to $627.2 million, down from $647.8 million in the same period last year. The company attributed this decline to a 4.2% drop in organic sales, primarily driven by volume declines in North America across its Wet Shave, Sun Care, and Feminine Care segments. Net earnings for the quarter were $29.1 million, a significant decrease from $49.0 million in the prior year, resulting in diluted earnings per share of $0.62 compared to $0.98.

In the nine-month period ending June 30, 2025, Edgewell's net sales totaled $1.686 billion, down 2.9% from $1.736 billion in the previous year. The company reported a net income of $56.0 million, down from $89.8 million, with diluted earnings per share decreasing from $1.79 to $1.17. The decline in profitability was attributed to lower sales and increased costs, including restructuring charges of $32.4 million for the nine months, compared to $13.1 million in the same period last year.

Operationally, Edgewell has been restructuring its operations to enhance efficiency, including consolidating its facilities in Mexico, which is expected to incur additional restructuring costs. The company also reported a 5.0% increase in advertising and sales promotion expenses for the third quarter, reflecting its strategy to bolster brand presence amid competitive pressures. The total employee headcount remained stable, with no significant changes reported.

Geographically, the company experienced a mixed performance, with international markets showing a slight organic growth of 2.2%, while North American sales fell by 8.0%. The Wet Shave segment reported net sales of $317.0 million, a marginal increase, while the Sun and Skin Care segment saw a 5.3% decline in sales. The Feminine Care segment also faced challenges, with a 10.5% drop in sales, reflecting ongoing market pressures.

Looking ahead, Edgewell anticipates continued challenges in the North American market but remains focused on its restructuring efforts and strategic initiatives to improve operational efficiency. The company expects to navigate through these market conditions while maintaining its commitment to innovation and brand development.